|
Subsequent Events
|
3 Months Ended | |
|---|---|---|
|
Sep. 30, 2013
|
||
| Subsequent Events [Abstract] | ||
| Subsequent Events [Text Block] | 14. Subsequent Events
Warrant Exercise Inducement On October 15, 2013, the Company announced that it was providing holders of its warrants issued as part of the January 2012 equity offering (the “January 2012 Warrants”) the opportunity to exercise at a reduced price for a limited period of time. The original exercise price of $0.88 was reduced to $0.40 until 5:00 p.m. on November 12, 2013 (the “Expiration Time”), after which the exercise price will revert back to $0.88 until these January 2012 Warrants expire on January 14, 2014. Except for the temporarily reduced exercise price, the terms of the January 2012 Warrants remain unchanged. As of October 31, 2013, pursuant to this warrant exercise inducement, the Company has issued 7.75 million shares of common stock and received exercise proceeds of approximately $3.1 million, net of expenses. NYSE Listing Compliance On October 25, 2013, the Company received notice from NYSE Regulation that iBio had resolved all previously cited continued listing deficiencies with respect to listing standards of the NYSE MKT LLC's (the "Exchange") Company Guide, and therefore continues its listing eligibility, subject, as is the case for all listed issuers, to assessment on an ongoing basis by the Exchange. Private Placement Offering
In November 2013, the Company completed a private placement offering of 1.2 million shares of its common stock for $0.40 per share, resulting in net proceeds of approximately $0.5 million.
|